Startseite Medizin Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay

  • Maja Hinge , Erik D. Lund , Ivan Brandslund , Torben Plesner und Jonna S. Madsen EMAIL logo
Veröffentlicht/Copyright: 11. August 2015

Abstract

Background: Quality control (QC) is an essential part of clinical biochemistry to ensure that laboratory test results are reliable and correct. Those tests without a defined reference method constitute a special challenge, as is the case with bone-specific alkaline phosphatase (BAP).

Methods and Results: The present study reports an example where a shift in a BAP assay was detected by use of a patient pool and supported by a retrospective calculation of “patient mean”, while the external QC and specific assay control material were unaffected by the shift.

Conclusions: Patient pools and the use of patient means remain a useful and inexpensive procedure for internal QC.


Corresponding author: Jonna S. Madsen, Department of Clinical Immunology and Biochemistry, Lillebaelt Hospital, Kabbeltoft 25, 7100 Vejle, Denmark; and Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark, Phone: +45 79406501; E-mail:

Acknowledgments

We would like to thank Liselotte Bjerregård Lauersen for her attentiveness in the laboratory work and for recognizing the steady increase in the results of BAP in the PP.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Ismail AA, Walker PL, Barth JH, Lewandowski KC, Jones R, Burr WA. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem 2002;48:2023–9.10.1093/clinchem/48.11.2023Suche in Google Scholar

2. Lapworth R, Teal TK. Laboratory blunders revisited. Ann Clin Biochem 1994;31:78–84.10.1177/000456329403100113Suche in Google Scholar PubMed

3. Witte DL, VanNess SA, Angstadt DS, Pennell BJ. Errors, mistakes, blunders, outliers, or unacceptable results: how many? Clin Chem 1997;43:1352–6.10.1093/clinchem/43.8.1352Suche in Google Scholar

4. Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011;22:391–420.10.1007/s00198-010-1501-1Suche in Google Scholar PubMed

5. Cavalier E, Souberbielle JC, Gadisseur R, Dubois B, Krzesinski JM, Delanaye P. Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients. Clin Biochem 2014;47:1227–30.10.1016/j.clinbiochem.2014.04.007Suche in Google Scholar PubMed

6. Bowers GN, Burnett RW, McComb RB. Preparation and use of human serum control materials for monitoring precision in clinical chemistry. Clin Chem 1975;21:1830–6.10.1093/clinchem/21.12.1830Suche in Google Scholar

7. ISO 15189:2012(E) Medical laboratories – Requirements for quality and competence. ISO: Geneva, 2012.Suche in Google Scholar

8. Henriksen GM, Pedersen MM, Norgaard I, Blom M, Blou L, Blaabjerg O, et al. Minimally processed fresh frozen human reference sera: preparation, testing, and application to international external quality assurance. Scand J Clin Lab Invest 2004;64:293–308.10.1080/00365510410006612Suche in Google Scholar PubMed

9. Broyles DL, Nielsen RG, Bussett EM, Lu WD, Mizrahi IA, Nunnelly PA, et al. Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase. Clin Chem 1998;44:2139–47.10.1093/clinchem/44.10.2139Suche in Google Scholar

10. Brinc D, Chan MK, Venner AA, Pasic MD, Colantonio D, Kyriakopolou L, et al. Long-term stability of biochemical markers in pediatric serum specimens stored at -80 degrees C: a CALIPER Substudy. Clin Biochem 2012;45:816–26.10.1016/j.clinbiochem.2012.03.029Suche in Google Scholar PubMed

11. Kazmierczak SC. Laboratory quality control: using patient data to assess analytical performance. Clin Chem Lab Med 2003;41:617–27.10.1515/CCLM.2003.093Suche in Google Scholar PubMed

12. Van Houcke SK, Stepman HC, Thienpont LM, Fiers T, Stove V, Couck P, et al. Long-term stability of laboratory tests and practical implications for quality management. Clin Chem Lab Med 2013;51:1227–31.10.1515/cclm-2012-0820Suche in Google Scholar PubMed

13. Wilson A, Roberts WL, Pavlov I, Fontenot J, Jackson B. Patient result median monitoring for clinical laboratory quality control. Clin Chim Acta 2011;412:1441–6.10.1016/j.cca.2011.04.024Suche in Google Scholar PubMed

14. Lott JA, Smith DA, Mitchell LC, Moeschberger ML. Use of medians and “average of normals” of patients’ data for assessment of long-term analytical stability. Clin Chem 1996;42:888–92.10.1093/clinchem/42.6.888Suche in Google Scholar

15. Stepman HC, Stöckl D, Stove V, Fiers T, Couck P, Gorus F, et al. Long-term stability of clinical laboratory data: sodium as benchmark. Clin Chem 2011;57:1616–7.10.1373/clinchem.2011.168195Suche in Google Scholar PubMed

16. Jørgensen LM, Hansen SI, Petersen PH, Sölétormos G. Median of patient results astool for assessment of analytical stability. Clin Chim Acta 2015;446:186–91.10.1016/j.cca.2015.04.024Suche in Google Scholar PubMed

Received: 2015-3-31
Accepted: 2015-7-8
Published Online: 2015-8-11
Published in Print: 2016-3-1

©2016 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. The way of prostate cancer diagnostics
  4. Review
  5. Statistical methods used in the calculation of geriatric reference intervals: a systematic review
  6. Opinion Paper
  7. The side effects of translational omics: overtesting, overdiagnosis, overtreatment
  8. Genetics and Molecular Diagnostics
  9. Rapid detection of non-deletional mutations causing α-thalassemia by multicolor melting curve analysis
  10. General Clinical Chemistry and Laboratory Medicine
  11. Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay
  12. Long-term stability of glucose: 96-h study using Terumo Glycaemia tubes
  13. Glucose is stable during prolonged storage in un-centrifuged Greiner tubes with liquid citrate buffer, but not in serum and NaF/KOx tubes
  14. Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples
  15. Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium
  16. Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood
  17. Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study
  18. Comparison of functional fibrinogen (FF/CFF) and FIBTEM in surgical patients – a retrospective study
  19. Reference Values and Biological Variations
  20. Assessment of serum free light chain levels in healthy adults immediately after marathon running
  21. Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients
  22. Cancer Diagnostics
  23. An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: a national scale study
  24. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
  25. Infectious Diseases
  26. Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma
  27. Evaluating the use of procalcitonin in an asymptomatic, HIV-infected antiretroviral therapy-naïve, South African cohort
  28. Diabetes
  29. Early prediction of gestational diabetes: a practical model combining clinical and biochemical markers
  30. Letters to the Editors
  31. Highly-trained dogs’ olfactory system for detecting biochemical recurrence following radical prostatectomy
  32. More on the accuracy of the Architect enzymatic assay for hemoglobin A1c and its traceability to the IFCC reference system
  33. Assessing quality from an accuracy-based HbA1c proficiency survey
  34. HbG-Honolulu interferes with some cation-exchange HPLC HbA1c assays
  35. Between analyser differences in chloride measurements and thus anion gap cause different interpretations of the acid-base balance
  36. Non-albumininuric proteinuria: a urinary tubular marker in the diagnosis of diabetic kidney disease
  37. International Normalized Ratio (INR) testing: analytical and clinical performance of four point-of-care devices versus central laboratory instrumentation analysis
  38. Genetic screening of the makorin ring finger 3 gene in girls with idiopathic central precocious puberty
  39. Practical approach for medical validation of therapeutic drug monitoring results
  40. Marked elevation of procalcitonin in a patient with a drug related infusion reaction to rituximab
Heruntergeladen am 23.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0308/html
Button zum nach oben scrollen